Dear Home Office,
On 1st November 2018 new regulations came into force which enabled the prescription of cannabis-based products for medicinal use (CBPMs) as schedule 2 drugs by specialist medical practitioners.
1. Please provide full details of what steps the Home Office has taken to facilitate the production of CBPMs in the UK including copies of all relevant documents.
2. What specific criteria will determine whether to grant a licence for the cultivation and/or production of CBPMs?
3. What specific requirements or obligations will be placed on applicants for licences for cultivation and/or production of CBPMs?
If any aspect of this request would exceed the cost limit for answering FOI Requests I will accept a summary of the information available.
Dear Mr. Reynolds,
Thank you for contacting the Home Office with your request.
This has been assigned to a caseworker (case ref 52481). We will aim to
send you a full response by 20/03/2019 which is twenty working days from
the date we received your request.
If you have any questions then please do not hesitate to contact us.
Please find attached our response to your Freedom of Information request.
2 Marsham Street, London, SW1P 4DF